126 related articles for article (PubMed ID: 32975078)
1. [Inhibition of Copper Transporter-1 by Ammonium Tetrathiocarbolybdate in the Treatment of Pancreatic Cancer].
Zhao YN; Chen LH; Yang XL; Dong JY; Wu WB; Chen D; Geng RM; Ke NW; Liu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Sep; 51(5):643-649. PubMed ID: 32975078
[TBL] [Abstract][Full Text] [Related]
2. Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition.
Dong YW; Wang XP; Wu K
World J Gastroenterol; 2009 Jan; 15(4):441-8. PubMed ID: 19152448
[TBL] [Abstract][Full Text] [Related]
3. Copper deprivation enhances the chemosensitivity of pancreatic cancer to rapamycin by mTORC1/2 inhibition.
Geng R; Ke N; Wang Z; Mou Y; Xiang B; Zhang Z; Ji X; Zou J; Wang D; Yin Z; Liu X; Xie F; Zhao Y; Chen D; Dong J; Wu W; Chen L; Cai H; Liu J
Chem Biol Interact; 2023 Sep; 382():110546. PubMed ID: 37290678
[TBL] [Abstract][Full Text] [Related]
4. Tetrahedral Framework Nucleic Acid Delivered RNA Therapeutics Significantly Attenuate Pancreatic Cancer Progression via Inhibition of CTR1-Dependent Copper Absorption.
Song G; Dong H; Ma D; Wang H; Ren X; Qu Y; Wu H; Zhu J; Song W; Meng Y; Wang L; Liu T; Shen X; Zhao Y; Zhu C
ACS Appl Mater Interfaces; 2021 Oct; 13(39):46334-46342. PubMed ID: 34549583
[TBL] [Abstract][Full Text] [Related]
5. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
6. The anti-tumor effects of the recombinant toxin protein rLj-RGD3 from Lampetra japonica on pancreatic carcinoma Panc-1 cells in nude mice.
Wang Y; Zheng Y; Tu Z; Dai Y; Xu H; Lv L; Wang J
Peptides; 2017 Feb; 88():8-17. PubMed ID: 27988354
[TBL] [Abstract][Full Text] [Related]
7. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death.
Yu Z; Zhou R; Zhao Y; Pan Y; Liang H; Zhang JS; Tai S; Jin L; Teng CB
Cell Prolif; 2019 Mar; 52(2):e12568. PubMed ID: 30706544
[TBL] [Abstract][Full Text] [Related]
8. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
9. Curcumin is a biologically active copper chelator with antitumor activity.
Zhang W; Chen C; Shi H; Yang M; Liu Y; Ji P; Chen H; Tan RX; Li E
Phytomedicine; 2016 Jan; 23(1):1-8. PubMed ID: 26902401
[TBL] [Abstract][Full Text] [Related]
10. High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells.
Li WG; Yuan YZ; Qiao MM; Zhang YP
World J Gastroenterol; 2012 Jun; 18(21):2630-9. PubMed ID: 22690071
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.
Li M; Yang H; Chai H; Fisher WE; Wang X; Brunicardi FC; Yao Q; Chen C
Cancer; 2004 Nov; 101(10):2341-50. PubMed ID: 15476280
[TBL] [Abstract][Full Text] [Related]
12. Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice.
Xiao Z; Li L; Li Y; Zhou W; Cheng J; Liu F; Zheng P; Zhang Y; Che Y
Cell Death Dis; 2014 May; 5(5):e1241. PubMed ID: 24853419
[TBL] [Abstract][Full Text] [Related]
13. [Expression of angiogenic factors in pancreatic carcinoma cell and their significance].
Yan CQ; Zhao YP
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):787-90. PubMed ID: 19615219
[TBL] [Abstract][Full Text] [Related]
14. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
Lu YY; Jing DD; Xu M; Wu K; Wang XP
World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma.
Long J; Liu Z; Hui L
BMC Complement Altern Med; 2019 Jun; 19(1):133. PubMed ID: 31215421
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells.
Nambiar D; Prajapati V; Agarwal R; Singh RP
Cancer Lett; 2013 Jun; 334(1):109-17. PubMed ID: 23022268
[TBL] [Abstract][Full Text] [Related]
18. Multitargeting Strategy Using Tetrathiomolybdate and Lenvatinib: Maximizing Antiangiogenesis Activity in a Preclinical Liver Cancer Model.
Nan L; Yuan W; Guodong C; Yonghui H
Anticancer Agents Med Chem; 2023; 23(7):786-793. PubMed ID: 36082862
[TBL] [Abstract][Full Text] [Related]
19. Autophagy inhibition improves the targeted radionuclide therapy efficacy of
Liu X; Li D; Ma T; Luo X; Peng Y; Wang T; Zuo C; Cai J
J Transl Med; 2024 Feb; 22(1):156. PubMed ID: 38360704
[TBL] [Abstract][Full Text] [Related]
20. Preclinical PET imaging study of lung cancer with
Wang Q; Song D; Ma X; Wu X; Jiang L
Ann Nucl Med; 2020 Sep; 34(9):653-662. PubMed ID: 32567008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
